INmune Bio Teams with Quantum Computing Inc. to Target New Indications for XPro

In an industry-first convergence of quantum photonics and precision medicine, INmune Bio Inc. (NASDAQ: INMB) and Quantum Computing Inc. (NASDAQ: QUBT) have entered into a commercial collaboration to apply quantum optimization, artificial intelligence, and advanced analytics to drug discovery. The jo...

Read it at International Business Times ↗

← Front page